Kerri Barton

1.1k total citations
13 papers, 134 citations indexed

About

Kerri Barton is a scholar working on Epidemiology, Clinical Biochemistry and Hepatology. According to data from OpenAlex, Kerri Barton has authored 13 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Clinical Biochemistry and 4 papers in Hepatology. Recurrent topics in Kerri Barton's work include Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Use and Resistance (4 papers) and Hepatitis C virus research (4 papers). Kerri Barton is often cited by papers focused on Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Use and Resistance (4 papers) and Hepatitis C virus research (4 papers). Kerri Barton collaborates with scholars based in United States. Kerri Barton's co-authors include Shauna Onofrey, Daniel Church, Alfred DeMaria, David J. Meyers, Thomas J. Stopka, Kenneth Chui, Gillian Haney, Alison Laufer Halpin, Alicia Shugart and Heather Moulton-Meissner and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Kerri Barton

13 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerri Barton United States 6 67 34 27 24 22 13 134
Annick Robinson Madagascar 7 60 0.9× 10 0.3× 21 0.8× 19 0.8× 11 0.5× 18 110
Marcello Feasi Italy 8 56 0.8× 42 1.2× 9 0.3× 34 1.4× 13 0.6× 15 124
Rafaël Mahieu France 8 37 0.6× 9 0.3× 18 0.7× 38 1.6× 19 0.9× 31 180
Kiana Shirani Iran 8 51 0.8× 12 0.4× 5 0.2× 65 2.7× 11 0.5× 31 168
Bahar Örmen Türkiye 7 90 1.3× 45 1.3× 16 0.6× 32 1.3× 14 0.6× 23 129
M Gale-Rowe Canada 9 94 1.4× 34 1.0× 27 1.0× 65 2.7× 23 1.0× 22 160
Wilma Basualdo Paraguay 6 84 1.3× 7 0.2× 17 0.6× 85 3.5× 23 1.0× 23 186
Fatma Yılmaz Karadağ Türkiye 7 79 1.2× 21 0.6× 3 0.1× 30 1.3× 11 0.5× 27 139
M Sláčiková Slovakia 4 65 1.0× 11 0.3× 24 0.9× 23 1.0× 17 0.8× 6 93
María Reneé López Guatemala 7 70 1.0× 3 0.1× 12 0.4× 31 1.3× 27 1.2× 19 135

Countries citing papers authored by Kerri Barton

Since Specialization
Citations

This map shows the geographic impact of Kerri Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri Barton more than expected).

Fields of papers citing papers by Kerri Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri Barton. The network helps show where Kerri Barton may publish in the future.

Co-authorship network of co-authors of Kerri Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Kerri Barton. A scholar is included among the top collaborators of Kerri Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerri Barton. Kerri Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Barton, Kerri, et al.. (2021). The Implementation of Telemedicine in the Covid-19 Era. 3(1). 2 indexed citations
3.
Tlachac, ML, et al.. (2020). Anomalous Antimicrobial Susceptibility Trend Identification. PubMed. 1024. 5880–5883. 1 indexed citations
4.
Klevens, R. Monina, et al.. (2020). Utilization of cumulative antibiograms for public health surveillance: Trends in Escherichia coli and Klebsiella pneumoniae susceptibility, Massachusetts, 2008–2018. Infection Control and Hospital Epidemiology. 42(2). 169–175. 1 indexed citations
5.
Barton, Kerri, et al.. (2018). Using public health surveillance data to measure Clostridium difficile infection population burden in Massachusetts. American Journal of Infection Control. 47(2). 211–212. 2 indexed citations
6.
7.
8.
Shenoy, Erica S., Virginia Pierce, Maroya Spalding Walters, et al.. (2018). Transmission of Mobile Colistin Resistance (mcr-1) by Duodenoscope. Clinical Infectious Diseases. 68(8). 1327–1334. 35 indexed citations
9.
Stopka, Thomas J., David J. Meyers, Kerri Barton, et al.. (2017). Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approach. BMC Infectious Diseases. 17(1). 294–294. 36 indexed citations
10.
Chang, Matthew S., Kerri Barton, Molly J. Crockett, et al.. (2016). Postpartum Laboratory Follow-up in Women With Hepatitis B in Massachusetts From 2007 to 2012. Journal of Clinical Gastroenterology. 50(6). e60–e64. 8 indexed citations
11.
Onofrey, Shauna, Jasneet Aneja, Gillian Haney, et al.. (2015). Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System. Annals of Internal Medicine. 163(4). 254–261. 26 indexed citations
12.
Chang, Matthew S., Kerri Barton, Molly J. Crockett, et al.. (2014). 700 Post-Partum Laboratory Follow-Up in Women With Hepatitis B in Massachusetts 2007-2012. Gastroenterology. 146(5). S–924. 2 indexed citations
13.
Duncan, Robert, et al.. (2012). Carbapenem-Resistant Enterobacteriaceae: A Statewide Survey of Detection in Massachusetts Hospitals. Infection Control and Hospital Epidemiology. 33(9). 954–956. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annick Robinson Breakdown of academic impact, for papers by Marcello Feasi Breakdown of academic impact, for papers by Rafaël Mahieu Breakdown of academic impact, for papers by Kiana Shirani Breakdown of academic impact, for papers by Bahar Örmen Breakdown of academic impact, for papers by M Gale-Rowe Breakdown of academic impact, for papers by Wilma Basualdo Breakdown of academic impact, for papers by Fatma Yılmaz Karadağ Breakdown of academic impact, for papers by M Sláčiková Breakdown of academic impact, for papers by María Reneé López
Rankless by CCL
2026